Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Mayo Clinic
University of Southern California
Memorial Sloan Kettering Cancer Center
Baptist Health South Florida
M.D. Anderson Cancer Center
Essen Biotech
Essen Biotech
M.D. Anderson Cancer Center
Kidney Cancer Research Bureau
Rigshospitalet, Denmark
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pardis Noor Medical Imaging and Cancer Center
University of Washington
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
Centre Georges Francois Leclerc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Leiden University Medical Center
NuCana plc
University Medical Center Groningen
Medical College of Wisconsin
Esperas Pharma Inc.
M.D. Anderson Cancer Center
CHU de Quebec-Universite Laval
Indiana University
Providence Health & Services
Fred Hutchinson Cancer Center
Jules Bordet Institute
M.D. Anderson Cancer Center
Shanghai Chest Hospital
Tongji Hospital
Gustave Roussy, Cancer Campus, Grand Paris
University of California, Davis
Icahn School of Medicine at Mount Sinai
University Medical Center Groningen
Augusta University
Capital Medical University
UMC Utrecht
Peter MacCallum Cancer Centre, Australia
University Hospital, Linkoeping
Fundacio Clinic Barcelona